Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 38, 2004 - Issue 5
Submit an article Journal homepage
104
Views
9
CrossRef citations to date
0
Altmetric
Research Article

A comparison of four different a1-blockers in benign prostatic hyperplasia patients with and without diabetes

Murat Bozlu Departments of Urology University of Mersin School of Medicine Mersin Turkey
,
Ercüment Ulusoy Departments of Urology University of Mersin School of Medicine Mersin Turkey
,
Selahittin Çayan Departments of Urology University of Mersin School of Medicine Mersin Turkey
,
Esen Akbay Department of Internal Medicine University of Mersin School of Medicine Mersin Turkey
,
Sadık Görür Departments of Urology University of Mersin School of Medicine Mersin Turkey
&
Erdem Akbay Departments of Urology University of Mersin School of Medicine Mersin Turkey
Pages 391-395 | Published online: 09 Jul 2009

References

  • Chute CG, Pander LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993; 150: 85–9.
  • Jolleys JV, Donovan JL, Nanchahal K, Peters TJ, Abrams P. Urinary symptoms in the community: how bothersome are they? Br J Urol 1994; 74: 551–5.
  • Frimodt-Moller C. Diabetic cystopathy: epidemiology and related disorders. Ann Intern Med 1980; 92: 318–21.
  • Ueda T, Yoshimura N, Yoshida 0. Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response. J Urol 1997; 157: 580–4.
  • Bourke JB, Griffin JP. Diabetes mellitus in patients with benign prostatic hyperplasia. Br Med J 1968; 4: 492–3.
  • Glynn RJ, Campion EW, Bouchard GR. The develop-ment of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol 1985; 121: 78–90.
  • Boon TA, Van Venrooij GE, Eckhardt MD. Effect of diabetes mellitus on lower urinary tract symptoms and dysfunction in patients with benign prostatic hyperplasia. Curr Urol Rep 2001; 2: 297–301.
  • Chapple CR. Pharmacotherapy for benign prostatic hyperplasia-the potential for ocl-adrenoceptor sub-type-specific blockade. Br J Urol 1998; 81 (Suppl 1): 34–47.
  • Michel MC, Schafers F, Goepel M. cc-Blockers and lower urinary tract function: more than smooth muscle relaxation? BJU Int 2000; 86 (Suppl 2): 23–30.
  • Roehrbom CG, Bartsch G, Kirby R, Andriole G, Boyle P, de la Rosette J, et al. Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative, international overview. Urology 2001; 58: 642–50.
  • Michel MC, Mehlburger L, Schumacher H, Bressel HU, Goepel M. Effects of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Urol 2000; 163: 1725–9.
  • Bozlu M, Doruk E, Akbay E, Cayan S, Acar D, Kanik EA. Effect of administration mode (patient vs physician) and patient's educational level on the Turkish version of the International Prostate Symptom Score. Int J Urol 2002; 9: 417–21.
  • Djavan B, Nickel JC, de la Rosette J, Abrams P. The urologist view of BPH progression: results of an inter-national survey. Eur Urol 2002; 41: 490–6.
  • Denis L, McConnell J, Yoshida 0, Khoury S, Abram P, Barry M, et al. Recommendations of the International Scientific Committee: the evaluation and treatment of lower urinary tract symptoms suggestive of benign prostatic obstruction. In: Denis L, Griffiths K, Khoury S, Cockett ATK, McConnell J, Chatelain C, et al., editors. Proc 4th Int Consultation on Benign Prostatic Hyperplasia (BPH). Plymouth, UK: Plymbridge Dis-tributors, 1998: pp. 669–83.
  • Chapple CR. Selective ocl-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience. Eur Urol 1996; 29: 129–44.
  • Djavan B, Marberger M. A meta-analysis on the effi-cacy and tolerability of alphal-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Eur Urol 1999; 36: 1–13.
  • Debruyne FMJ. Alpha blockers: are all created equal? Urology 2000; 56 (Suppl 5A): 20–2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.